RSO-021

· RS Oncology LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RSO-021, covering 2024-01-26 to 2024-01-26. Get the full timeline:

Most recent: Clinical Trial Update: Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma [Phase 1, Phase 2]

See pricing